Lgr5 knockdown was shown to induce cell death[36], and furthermore, a recently-developed monoclonal antibody (KM4056) was reported to have potent complement-dependent cytotoxicity activity in vitro, and to show strong anti-tumor activity in vivo[37]. This evidence concerns the gene LGR5 and neoplasm.